Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024
June 06, 2024 14:56 ET
|
Scilex Holding Company
Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.Gout is a painful arthritic disorder affecting...
TOMI Environmental Solutions, Inc. Announces Cost Reduction Efforts to Sustain Long Term Growth and Achieve Profitability
June 06, 2024 12:45 ET
|
TOMI Environmental Solutions, Inc.
Company restructures executive compensation and reduces external consulting fees Expects to reduce cash used in operations by 30% (Approximately $500,000) by end of 2024 Company to continue to...
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC
June 06, 2024 12:14 ET
|
CG Oncology Inc.
CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab
QXO Announces Leadership Team and Board of Directors
June 06, 2024 11:49 ET
|
QXO, Inc.
GREENWICH, Conn., June 06, 2024 (GLOBE NEWSWIRE) -- Brad Jacobs, chairman and chief executive officer of QXO, Inc. (Nasdaq: QXO), today announced the appointment of eight executives and six members...
QXO Completes $1 Billion Equity Investment
June 06, 2024 11:46 ET
|
QXO, Inc.
GREENWICH, Conn., June 06, 2024 (GLOBE NEWSWIRE) -- QXO, Inc. (“QXO” or the “Company”), formerly known as SilverSun Technologies, Inc. (“SilverSun”), today completed the previously announced equity...
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
June 06, 2024 11:15 ET
|
Arbutus Biopharma Corporation
Data highlighted in oral presentation at the European Association for the Study of the Liver (EASL) Congress WARMISTER, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation...
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
June 06, 2024 11:15 ET
|
Barinthus Biotherapeutics
Barinthus Bio presents updated data from two clinical trials in people with chronic hepatitis B at EASL Congress 2024.
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
June 06, 2024 11:00 ET
|
Tonix Pharmaceuticals Holding Corp.
CHATHAM, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), fully-integrated biopharmaceutical company with marketed products and a...
Freshworks Completes Acquisition of Device42
June 06, 2024 10:55 ET
|
Freshworks Inc
Enhances IT Asset Management Capabilities Designed to Provide Customers with a Single, Integrated Platform New Capabilities Help Customers Reduce Risk, Solve Incidents Faster SAN MATEO, Calif.,...
Rapid7 Wins Best SIEM Solution at SC Awards Europe 2024
June 06, 2024 10:14 ET
|
Rapid7
BOSTON, June 06, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that InsightIDR was recognized as Best SIEM Solution at the SC...